A Haeberli Selected Research

Fibrin

11/2002	Coagulation markers predict survival in cancer patients.
2/2001	Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Haeberli Research Topics

Disease

1	Lactic Acidosis 04/2016
1	Deafness (Deaf Mutism) 04/2016
1	Fanconi Syndrome (Syndrome, Fanconi) 04/2016
1	Microcephaly 04/2016
1	Neoplasms (Cancer) 11/2002
1	Hemorrhage 02/2001
1	Unstable Angina 09/2000
1	Myocardial Infarction 09/2000

Drug/Important Bio-Agent (IBA)

2	FibrinIBA 11/2002 - 02/2001
1	polyacrylamideIBA 04/2016
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 04/2016
1	AntibodiesIBA 02/2001
1	Complement System Proteins (Complement)IBA 02/2001
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2000
1	Clopidogrel (Plavix)FDA Link 09/2000

Therapy/Procedure

1	Secondary Prevention 09/2000
1	Therapeutics 09/2000